Cargando…

Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis

BACKGROUND: Chronic kidney disease (CKD) is associated with poorer outcomes following percutaneous coronary intervention (PCI) with drug-eluting stents. Drug-eluting balloons are used for in-stent restenosis and selected cases of de-novo coronary lesions. Little is known regarding the outcomes of in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonas, Michael, Kagan, Maayan, Sella, Gal, Haberman, Dan, Chernin, Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583297/ https://www.ncbi.nlm.nih.gov/pubmed/33097001 http://dx.doi.org/10.1186/s12882-020-02089-w

Ejemplares similares

Predictors of Inappropriately Rapid Coronary Lesion Progression in Patients Undergoing Percutaneous Coronary Interventions
por: Sella, Gal, et al.
Publicado: (2023)

Mid-Term Clinical Outcomes Following Drug-Coated Balloons in Coronary Artery Disease
por: Sella, Gal, et al.
Publicado: (2022)

Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation
por: Kammerer, Tobias, et al.
Publicado: (2014)

Two Cases of Percutaneous Intervention for Coronary Artery Bypass Graft Anastomoses With Paclitaxel-Eluting Balloon Catheters
por: Uhm, Jae-Sun, et al.
Publicado: (2011)

Utilization of Drug-Coated Balloons for the Treatment of Coronary Lesions in the Elderly Population
por: Sella, Gal, et al.
Publicado: (2022)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
por: Taherioun, Mehrdad, et al.
Publicado: (2014)

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention
por: Zhao, Hui, et al.
Publicado: (2023)

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?
por: Merinopoulos, Ioannis, et al.
Publicado: (2018)

Balloon-assisted tracking for challenging transradial percutaneous coronary intervention
por: Agelaki, Maria, et al.
Publicado: (2017)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas, Vasileios F, et al.
Publicado: (2015)

Adverse Cardiovascular Outcomes associated with Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention with Everolimus Eluting Stents: A Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Balloon Occlusion Types in the Treatment of Coronary Perforation during Percutaneous Coronary Intervention
por: Wang, Xiangfei, et al.
Publicado: (2014)

Coronary pseudoaneurysm 1 week after complex percutaneous coronary intervention with drug‐eluting stent
por: Namazi, Mohammad Hasan, et al.
Publicado: (2020)

One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016)

Drug-eluting balloon: is it useful?
por: Laksono, Sidhi, et al.
Publicado: (2020)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022)

Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
por: Park, Sun-Kyung, et al.
Publicado: (2017)

Newer-Generation Drug-Eluting Stents in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Otsuka, Kenichiro
Publicado: (2021)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Koni, Endrin, et al.
Publicado: (2021)

A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease
por: Lee, Hak-Il, et al.
Publicado: (2021)

Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention
por: El Khoury, Rym, et al.
Publicado: (2023)

Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
por: Yeh, Robert W, et al.
Publicado: (2011)

Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management
por: Alam, Mohammed Shakawat, et al.
Publicado: (2020)

Intra-aortic Balloon Counterpulsation for High-Risk Percutaneous Coronary Intervention: Defining Coronary Responders
por: Briceno, Natalia, et al.
Publicado: (2019)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty – case report and review of the literature
por: Vassilev, Dobrin, et al.
Publicado: (2015)

Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review
por: Richelsen, Rasmus Kapalu Broge, et al.
Publicado: (2016)

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis
por: Lee, Wei-Chieh, et al.
Publicado: (2015)

Sirolimus-Eluting Balloon for the Treatment of Coronary Lesions in Complex ACS Patients: The SELFIE Registry
por: Caiazzo, Gianluca, et al.
Publicado: (2020)

Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents
por: Bibi, Salma, et al.
Publicado: (2022)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Era of Newer-Generation Drug-Eluting Stents
por: Kim, Su-Min, et al.
Publicado: (2017)

Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting
por: Pedersen, Susanne S., et al.
Publicado: (2010)

Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents
por: Kubo, Motoki, et al.
Publicado: (2015)

Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era
por: Kim, Hack-Lyoung, et al.
Publicado: (2019)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Balloon-assisted tracking for challenging transfemoral percutaneous coronary intervention: a case report
por: Merella, Pierluigi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ver00snre5g0b6939g6jpgqkpe